Skip to content

Clinical trials

Hepatic Encephalopathy trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatic Encephalopathy Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20061
20131
20152
20181
20211
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imperial College London2
Resolution Therapeutics Limited2
University of Pittsburgh2
Axcella Health, Inc1
Bausch Health Americas, Inc.1
King's College Hospital NHS Trust1
King's College London1
Norgine1
Prof. Valérie Mc Lin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatic Encephalopathy12
Fibrosis5
Liver Cirrhosis5
End Stage Liver Disease3
Liver Failure, Acute2
Congenital Portosystemic Shunt1
Fatty Liver, Alcoholic1
Hepatic Insufficiency1
Hepatopulmonary Syndrome1
Hyperammonemia1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.